Quick Answer
Opus Genetics, Inc. reported Total Revenue of $14.20 million for fiscal year 2025.
Opus Genetics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $14.20M | +29.1% |
| 2024 | $10.99M | -42.3% |
| 2023 | $19.05M | -52.2% |
| 2022 | $39.85M | +6665.7% |
| 2021 | $589.0K | — |
| 2020 | $0.00 | — |
| 2013 | $0.00 | — |
| 2012 | $0.00 | — |
| 2011 | $0.00 | — |
| 2010 | $0.00 | — |
| 2009 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.08M | -20.4% | +6.8% |
| June 30, 2025 | $2.88M | +159.2% | -34.1% |
| March 31, 2025 | $4.37M | +155.4% | +13.0% |
| September 30, 2024 | $3.87M | -67.6% | +247.8% |
| June 30, 2024 | $1.11M | -69.7% | -35.0% |
| March 31, 2024 | $1.71M | -2.2% | -85.7% |
| September 30, 2023 | $11.94M | — | +224.9% |
| June 30, 2023 | $3.67M | — | +110.1% |
- Opus Genetics, Inc. showed an increase of +29.1% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from Opus Genetics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: